Please use this identifier to cite or link to this item:
https://repository.iimb.ac.in/handle/2074/21663
DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | Dasgupta, Kunal | |
dc.contributor.author | Mondal, Piyush | |
dc.contributor.author | Bhesdadiya, Anand Bharatkumar | |
dc.date.accessioned | 2022-10-24T12:10:47Z | - |
dc.date.available | 2022-10-24T12:10:47Z | - |
dc.date.issued | 2021 | |
dc.identifier.uri | https://repository.iimb.ac.in/handle/2074/21663 | - |
dc.description.abstract | Indian pharma industry is predicted to cross market valuation of US $130 bn. by 2030. India seems a huge market ranking 3'd globally in production by volume and 14'h by value. There are 3000 drug companies & more than 10000 manufacturing fim1s in the subcontinent; offering India a strong standing worldwide. In terms of exports, India stands at US$ 20.70 bn. in FY 20 and US$ 24.44 bn. in FY 21. The growth rate of this sector is also very impressive with CAGR of 22.4% in the coming years. Moreover, India has the 2nd highest manpower employed in biotech & pharma industry worldwide. The rise of healthcare and biotech industry serves as a perfect complementary for this already att ractive sector. | |
dc.publisher | Indian Institute of Management Bangalore | |
dc.relation.ispartofseries | PGP_CCS_P21_157 | |
dc.subject | Pharmaceutical industry | |
dc.subject | Markets | |
dc.subject | Trade | |
dc.title | Study on pharma sector, exports: Analysing African markets and trade conditions | |
dc.type | CCS Project Report-PGP | |
dc.pages | 31p. | |
Appears in Collections: | 2021 |
Files in This Item:
File | Size | Format | |
---|---|---|---|
PGP_CCS_P21_157.pdf | 4.64 MB | Adobe PDF | View/Open Request a copy |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.